Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,055,716
+$735,694 QoQ
Shares Held
24,065
-1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,199
of 4,153 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLOBALT Investments LLC / GA holds $66,458,169 across 7 Drug Manufacturers - General names. ABBV ranks #6 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,538 | $17,437,314 | |
| 2 | JNJ |
Johnson & Johnson
|
52,696 | $13,383,203 | |
| 3 | AMGN |
Amgen Inc
|
27,727 | $10,040,501 | |
| 4 | MRK |
Merck & Co., Inc.
|
56,795 | $7,298,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
53,145 | $6,714,339 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
24,065 | $6,055,716 | |
| 7 | AZN |
Astrazeneca PLC
|
29,158 | $5,528,939 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,055,716 | 24,065 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,320,022 | 24,461 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,699,911 | 24,946 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,974,889 | 25,805 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $4,857,675 | 26,170 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,817,283 | 22,992 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,111,622 | 23,138 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,782,926 | 19,156 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||